Showing results (3001-3010 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 12, 2012
YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-αArio Takeuchi, Masaki Shiota, Katsunori Tatsugami, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2015
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonistsRuiKun Zhong, Hongying Li, Karen Messer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Canine lymphoma-associated antigens defined by murine monoclonal antibodiesZ Steplewski, K A Jeglum, C Rosales, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populationsR Agah, H Shau, A Mazumder
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2W Budzynski, M Chirigos, E Gruys
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trialH Blomgren, I Näslund, P L Esposti, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Sensitization of human tumor cells to homologous complement by vaccinia virus treatmentH Okada, N Wakamiya, N Okada, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2022
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphomaAlexej Ballhausen, Amin Ben Hamza, Carlotta Welters, et al.
Cancer Immunology, Immunotherapy : CII|August 17, 2022
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancerMaud Rijnders, Debbie G J Robbrecht, Astrid A M Oostvogels, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2023
Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoireDouglas G Millar, S Y Cindy Yang, Azin Sayad, et al.
Pageof 652